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Abstract 26 
Percentiles 10th, 25th, 50th, 75th and 90th are presented for total circulating white blood cells 27 
(WBC), neutrophils, lymphocytes, monocytes, eosinophils and basophils in healthy European 28 
adolescents (12.5-17.5 years, n=405, 48.9% boys), considering age, sex, puberty and body mass 29 
index (BMI). CD3+ (mature T cells), CD4+ (T helper), CD8+ (T cytotoxic), CD16+56+ (natural 30 
killer), CD19+ (B cells), CD45RA+ (naïve) and CD45RO+ (memory) lymphocytes were also 31 
analysed by immunophenotyping. Girls presented higher WBC, neutrophil, CD3+CD45RO+ and 32 
CD4+CD45RO+ cell counts and CD3+/CD19+ ratio, and lower CD3+CD45RA+ and 33 
CD4+CD45RA+ counts than boys. Age was associated with higher neutrophil counts and 34 
CD3+/CD19+ ratio and lower CD19+ counts; in boys, with lower CD3+CD45RA+, 35 
CD4+CD45RA+ and CD8+CD45RA+ counts as well; in girls, with higher WBC, CD3+CD45RO+, 36 
and CD4+CD45RO+ counts. Pubertal maturation in boys was associated with lower WBC and 37 
lymphocyte counts; in girls, with higher basophil, CD3+CD45RO+ and CD4+CD45RO+ values. 38 
BMI was associated with higher WBC counts; in boys, also with higher lymphocyte counts; in 39 
girls, with higher neutrophil, CD4+, CD3+CD45RO+ and CD4+CD45RO+ counts. Conclusions: 40 
Our study provides normative values for circulating immune cells in adolescents, highlighting 41 
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the importance of considering sex, age, pubertal maturation and BMI when establishing 42 
reference values for WBC in paediatric populations. 43 
Key words: adolescents; immune cells; immunophenotyping; sex; puberty; body mass index.  44 
Abbreviations used 45 
BMI – body mass index 46 
WBC – white blood cells 47 
What is known? 48 
Reference values for white blood cell counts and immunophenotyping of lymphocyte subsets can 49 
constitute useful clinical tools and health indicators in both adult and paediatric populations. 50 
Like other health indicators, they can vary according to a number of factors, such as age or sex.  51 
What is new? 52 
Specific data from WBC in European adolescents are limited, and even less is known about 53 
changes in lymphocyte subsets during adolescence. This work provides normative values 54 
obtained from adolescents from 9 European countries, considering the influence of sex, age, 55 
pubertal maturation and BMI and finding that: 56 
 Girls had higher WBC, neutrophil and CD45RO+ (memory) cell values, while boys had 57 
higher percentages of lymphocytes, monocytes and eosinophils and CD45RA+ (naive) 58 
cell counts. 59 
 Age was associated with higher WBC, neutrophil, CD45RO+ and CD3+/CD19+ values, 60 
and lower percentage of total lymphocytes and CD45RA+ cell counts.  61 
 Pubertal maturation was associated, on the contrary, with lower WBC and lymphocytes, 62 
but only in boys. In girls, pubertal maturation was linked to higher CD45RO+ cell counts. 63 
 BMI was associated with higher WBC, mainly due to greater lymphocyte counts in boys, 64 
and to neutrophil and CD45RO+ cell counts in girls.  65 
 4 
Introduction 66 
Total white blood cell (WBC) counts and the evaluation of the different subtypes of white blood 67 
cells are useful clinical indicators and are frequently used as diagnostic tools for adults as well as 68 
for children. Besides providing information on acute inflammatory and infectious states, the 69 
immunological status serves as an indicator of many other physiological processes, and immune 70 
markers are becoming increasingly used to study alterations other than infections – for example, 71 
as early as in the 70s, Friedman and colleagues reported an association between WBC count and 72 
myocardial infarction [9]. Immune function is closely related to overall health and nutritional 73 
status [31], and during the last decade, WBC count has been related to different metabolic 74 
alterations, such as impaired glucose tolerance, type 2 diabetes mellitus, obesity, or the metabolic 75 
syndrome, and this has been observed in adults [10, 25] as well as in children and adolescents [5, 76 
36]. The analysis of lymphocyte subsets by flow cytometry (known as immunophenotyping) is 77 
an ever more widely used tool not only for assessing health status but also specifically in 78 
nutritional evaluation, and helps identify subjects at risk of disease. 79 
Adequate and reliable reference values from healthy populations become a key point in 80 
the clinical use of any biological parameter. Variations can occur as a consequence of 81 
physiological, ethnic or environmental factors; therefore, normative values should be specific for 82 
a given population group. For example, childhood and adolescence are growth periods in which 83 
all the systems in the body are developing physically and functionally. The immune system itself 84 
experiences a series of modifications from birth until adulthood; during childhood and 85 
adolescence the immune cells vary in both their number and functionality [1, 6, 8, 13, 16, 18, 28, 86 
32, 34]. Therefore, normative values for immune cells obtained from adult populations can be 87 
misleading when applied to children and adolescents. In addition, sex-related and even ethnicity-88 
related variations in the values of circulating immune cells have been acknowledged [1, 4, 7, 17, 89 
28, 29, 34, 38,], highlighting the importance of providing reference values for specific 90 
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population groups and geographical areas. However, information about WBC counts and specific 91 
lymphocyte subsets on healthy adolescents is still scarce [1, 8, 16, 28, 32, 34], as most available 92 
data belong to populations with particular immune-related diseases, or the studies, although 93 
useful and informative, have usually been conducted on relatively modest sample sizes for this 94 
particular age group. 95 
The present study aims to provide normative ranges for total and differential WBC counts 96 
and for selected lymphocyte subsets in a representative sample of healthy European adolescents, 97 
attending to variations due to sex, age, degree of pubertal maturation, and body mass index. 98 
 99 
METHODS 100 
Study design and sample selection 101 
A European multicentre cross-sectional study (CSS) was performed with the objective of 102 
assessing a “healthy lifestyle in Europe by nutrition in adolescence” (HELENA). The HELENA-103 
CSS aimed to obtain reliable and comparable data on nutrition and other health indicators such 104 
as physical activity and fitness, body composition, cardiovascular disease risk factors, vitamin 105 
and mineral status, and immunological and genetic markers in European adolescents [21]. The 106 
methodology used in this study has been published elsewhere [20]. The study was performed 107 
according to the ethical guidelines of the Edinburgh revision of the 1964 Declaration of Helsinki 108 
(2000), the International Conferences on Harmonization for Good Clinical Practice and the 109 
legislation on clinical research from each of the participating countries. The protocol was 110 
approved by the Research Ethics Committees of the participating centres. Written informed 111 
consent was obtained from the parents of the adolescents and from the adolescents themselves 112 
[2]. 113 
Briefly, subjects aged 12.5-17.5 years were recruited randomly from schools in ten cities 114 
belonging to nine countries across Europe (Athens and Heraklion in Greece, Dortmund in 115 
 6 
Germany, Ghent in Belgium, Lille in France, Pècs in Hungary, Rome in Italy, Stockholm in 116 
Sweden, Vienna in Austria and Zaragoza in Spain). The total eligible HELENA-CSS population 117 
consisted of 3,528 adolescents. Blood samples were obtained in one third of participants, 118 
resulting in a representative subpopulation of 1,089 adolescents (approximately 100 boys and 119 
girls per city). The size of this subpopulation was previously calculated as sufficient to account 120 
for the expected variability in blood measurements. 121 
 122 
Data exclusion 123 
Those subjects with conditions that might interfere with or imply stimulation of normal immune 124 
function were excluded from the analysis. Exclusion criteria included: suffering from allergies, 125 
suffering from fever on the 24 hours prior to blood sampling, having had a cold or any infection 126 
during the week prior to the day of blood sampling, having taken any medication in the previous 127 
24 hours or for more than 7 days in the previous 30 days, having taken any vitamin or mineral 128 
supplement during the previous month, and having been vaccinated in the two weeks prior to the 129 
day of blood sampling. After applying these exclusion criteria, the final study population 130 
consisted of 405 subjects (48.9% boys). 131 
 132 
Measurements of pubertal maturation and body mass index 133 
Evaluation of the degree of pubertal maturation was assessed by a medical doctor, according to 134 
the Tanner and Whitehouse classification [33]. Anthropometric data were also collected 135 
following harmonized protocol procedures previously described [23]. Body mass index (BMI) 136 
was calculated as: body weight (kg) / [height (m)]2. Standardized BMI values (z-scores) were 137 
calculated and the sample was classified according to quartiles of standardized BMI values. 138 
 139 
Blood sampling, white blood cell profiling and immunophenotyping 140 
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Venous blood samples were collected in EDTA Monovette (Sarstedt, Germany) tubes between 141 
8.00 and 10.00 a.m. after a 12-hour overnight fast. WBC counts and percentages were 142 
determined in each participating city with automated blood cell counters. For immuno-143 
phenotyping of lymphocyte subsets, blood samples were collected in EDTA-K3E Vacutainer 144 
(BD Biosciences) tubes. Blood aliquots were taken into 1.5 ml plastic tubes and diluted 1:1 with 145 
Cytochex™ Reagent (Streck Laboratories, Omaha, NE, USA). The samples were all sent to the 146 
CSIC group laboratory (Madrid, Spain) within 7 days from collection. The methodology for 147 
WBC determination and for collection, preparation and shipping of the blood samples to Madrid 148 
was standardized amongst all participating cities [11]. 149 
 150 
Immunophenotyping 151 
Blood aliquots were incubated for 30 minutes at room temperature in the dark with 152 
fluorochrome-conjugated monoclonal antibodies (BD Biosciences, San José, CA, USA), to 153 
differentially label those cells positive for the surface markers CD45 (the pan-leukocyte marker), 154 
CD3 (T mature cells), CD4 (helper T cells), CD8 (cytotoxic T cells), CD19 (B cells), CD16+56 155 
(natural killer cells), CD45RO (memory cells) and CD45RA (naïve cells). A quadruple 156 
immunostaining procedure was performed as follows: CD3/CD8/CD45/CD4, 157 
CD45RA/CD45RO/CD8/CD3, CD45RA/CD45RO/CD4/CD3 and CD3/CD16+56/CD45/ /CD19. 158 
After lysis of red blood cells, lymphocytes were analysed by flow cytometry (FACScan Plus 159 
Dual Laser, Becton Dickinson Sunnyvale, CA). The lympho-gate was defined on the forward 160 
and side scatter patterns of lymphocytes. The analysis protocol gated on lymphocytes stained 161 
with PerCP and/or APC and the selected population was then analysed with the two remaining 162 
colours (FITC and PE) to obtain percentages of cell expressing the specific antigens.   163 
Percentages of the following lymphocyte subsets were obtained: total mature T cells 164 
(CD45+CD3+, or CD3+ for simplicity), helper T cells (CD45+CD3+CD4+, or CD4+), cytotoxic T 165 
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cells (CD45+CD3+CD8+, or CD8+), natural killer (NK) cells (CD45+CD3–16+56+, or CD16+56+), 166 
B cells (CD45+CD3–CD19+, or CD19+), naïve T cells (CD3+CD45RA+, CD4+CD45RA+ and 167 
CD8+CD45RA+, or CD3RA+, CD4RA+ and CD8RA+), and memory T cells (CD3+CD45RO+, 168 
CD4+CD45RO+ and CD8+CD45RO+, or CD3RO+, CD4RO+ and CD8RO+). Absolute cell counts 169 
were calculated from total lymphocyte numbers, which were determined with automated blood 170 
cell counters in each participating city. The CD4+/CD8+ and the CD3+/CD19+ ratios were also 171 
calculated. 172 
 173 
Statistical analysis 174 
All the analyses conducted on the HELENA-CSS data were adjusted by a weighing factor to 175 
balance the studied population according to the age and sex distribution of the theoretical 176 
sample. Adolescents were grouped into four age categories: 12.5-13.9 years (from 12.5 years to 177 
the day before the 14th birthday), 14-14.9 years (from the 14th birthday to the day before the 15th 178 
birthday), 15-15.9 years (from the 15th birthday to the day before the 16th birthday), and 16-17.5 179 
years (from the 16th birthday to 17.5 years). The Chi-squared (Χ2) test was used to compare 180 
frequencies of sex, age categories, and Tanner stages between the studied and the excluded 181 
groups, as well as to compare frequencies of age categories and Tanner stages between sexes. 182 
Absolute counts and percentages of cells are presented as percentiles 10th, 25th, 50th 183 
(median), 75th and 90th for description of the population classified by sex and age. Data were 184 
then studied according to sex, age, Tanner stage and standardized BMI categories. Normality of 185 
variables was checked by the Kolmogorov-Smirnov test, and those not normally distributed were 186 
appropriately transformed when necessary. 187 
Differences between sexes were analysed with the Mann-Whitney U test. Subsequent 188 
tests to assess the influence of age, pubertal maturation and BMI were conducted separately in 189 
boys and girls. Associations between cell values and age and between cell values and BMI were 190 
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assessed with Pearson partial correlation test, controlling for city of origin (centre). Differences 191 
in cell values between Tanner stages and BMI categories were assessed by analysis of 192 
covariance (ANCOVA), adjusting for centre (and age when comparing Tanner stages). Due to 193 
the small number of individuals found within Tanner stages I and II, these two groups were 194 
combined to allow statistical analysis. 195 
Statistical significance was set at P<0.05. All statistical analyses were performed with 196 
IBM® SPSS® Statistics v.19 for Windows. 197 
 198 
RESULTS 199 
Characteristics of the population 200 
There were no differences in the proportions of sexes between included and excluded 201 
adolescents (48.9 vs. 45.5% boys; Χ2 = 1.196, P = 0.274). Similarly, no significant differences 202 
were found in the distributions of age categories (Χ 2 = 1.146, P = 0.766), Tanner stages 203 
(Χ2 = 3.851, P = 0.278) or BMI categories (Χ2 = 7.164, P = 0.067) between the adolescents 204 
included in the analysis and their excluded peers. 205 
The average age of the studied population was 14.9 ± 1.2 years (range 12.5-17.4 y). 206 
There were significantly fewer adolescents between 16 and 17.5 years (22%) than in the other 207 
age groups (Χ2 = 16.392, P < 0.01). In relation to pubertal maturation, most of the adolescents 208 
(78.2%) were found at either the IV or V Tanner stages, as could be expected according to the 209 
age range. Boys and girls were similar in age, Tanner stage distributions and mean BMI values 210 
in each quartile of BMI z-scores (boys: 17.7 ± 1.1 (Q1), 19.8 ± 0.8 (Q2), 21.8 ± 1.2 (Q3), and 211 
27.0 ± 3.2 (Q4) kg/m2; girls: 17.9 ± 1.1 (Q1), 20.0 ± 0.8 (Q2), 22.0 ± 1.1 (Q3), and 26.3 ± 3.0 212 
(Q4) kg/m2). 213 
 214 
 215 
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Influence of sex on immune cell counts and percentages 216 
Statistical comparison between sexes showed that girls in general presented higher values for 217 
total WBC and neutrophil counts (table 1). Percentages of neutrophils were also higher in girls, 218 
while those of lymphocytes, monocytes and eosinophils were greater in boys (supplementary 219 
table 1). 220 
Table 2 shows the percentiles 10th, 25th, 50th (median), 75th and 90th of the absolute 221 
counts of the selected lymphocyte subsets, separately by sex and group of age. Percentiles of the 222 
lymphocyte subsets percentages can be found in supplementary table 2. Boys showed a 223 
tendency to higher counts of CD3+CD45RA+ and CD4+CD45RA+ naïve cells (differences 224 
significant at 14-14.9 y), while girls presented higher counts of CD3+CD45RO+ (differences 225 
being significant at 14-14.9 and 16-17.5 y) and CD4+CD45RO+ memory cells (significant at 16-226 
17.5 y). The ratio CD3+/CD19+ was also higher in girls (difference being significant at 15-15.9 227 
years) (table 2). Similarly, boys had higher percentages of CD3+CD45RA+ (significant at 14-228 
14.9 y and 16-17.5 y), CD4+CD45RA+ and CD8+CD45RA+ (differences significant at 14-14.9 y); 229 
girls in turn had higher percentages of CD3+ and CD4+ (differences significant at 15-15.9 y), 230 
CD3+CD45RO+ (differences significant at 14-14.9 and 16-17.5 y), CD4+CD45RO+ and 231 
CD8+CD45RO+ (differences significant at 14-14.9 y) (supplementary table 2). 232 
 233 
Influence of age on immune cell counts and percentages 234 
Total WBC and neutrophil counts increased with age in the total population (r = 0.121, P = 0.015 235 
and r = 0.153, P = 0.003, respectively; and table 1). Neutrophil percentages also increased with 236 
age, while the percentage of lymphocytes decreased, both in the total population (r = 0.167 and 237 
r = −0.173, respectively, P = 0.001) and in boys (supplementary table 1). 238 
Age was also associated with increased counts of CD4+CD45RO+ (r = 0.179, P = 0.001) 239 
and the ratio CD3+/CD19+ (r = 0.240, P < 0.001), and decreased counts of CD19+ (r = −0.250, 240 
 11 
P < 0.001), CD3+CD45RA+ (r = −0.118, P = 0.036), and CD4+CD45RA+ (r = −0.124, 241 
P = 0.027). The percentages of these subsets showed the same relationships with age (%CD19+: 242 
r = −0.255; %CD3+CD45RA+: r = −0.184; %CD4+CD45RA+: r = −0.238; %CD3+CD45RO+: 243 
r = 0.206; %CD4+CD45RO+: r = 0.235; all P < 0.01). In boys alone, age was inversely 244 
correlated with counts of CD19+, CD8+ and naïve cells (CD3+CD45RA+, CD4+CD45RA+ and 245 
CD8+CD45RA+), and positively with the ratio CD3+/CD19+ (table 2). In girls alone, older age 246 
was associated as well with lower CD19+ and higher CD3+/CD19+, but also with increased 247 
counts of CD3+CD45RO+ and CD4+CD45RO+ (table 2). As a result, in both boys and girls there 248 
was a trend to decreased percentages of naïve cells and increased of memory cells with age 249 
(supplementary table 2). 250 
 251 
Influence of pubertal maturation on immune cell counts and percentages 252 
In boys, pubertal maturation (Tanner stage) was associated with lower WBC and lymphocyte 253 
counts, independently of age (table 3); lymphocyte percentages were also lower in more 254 
developed Tanner stages (supplementary table 3). This decrease was reflected in most 255 
lymphocyte subsets: CD3+, CD4+, CD8+, CD19+, CD3+CD45RA+, CD3+CD45RO+, 256 
CD4+CD45RO+, CD8+CD45RA+ and CD8+CD45RO+ cell counts were all lower in more 257 
advanced Tanner stages (table 4). 258 
In girls, higher basophil counts (table 3) and percentages (supplementary table 3), and 259 
CD3+CD45RO+ and CD4+CD45RO+ cell counts were higher in more advanced pubertal 260 
maturation stages (table 4). 261 
 262 
Influence of BMI on immune cell counts and percentages 263 
In boys, counts of total WBC, neutrophils and lymphocytes were higher with increasing BMI 264 
(table 5). The increase in lymphocyte counts was reflected in most subsets (CD3+, CD4+, CD8+, 265 
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natural killer, CD19+, CD3+CD45RO+, CD4+CD45RO+ and CD8+CD45RO+), whereas the ratio 266 
CD4+/CD8+ (table 6) and the percentages of naïve cells (CD3+CD45RA+ and CD4+CD45RA+) 267 
decreased (supplementary table 6). 268 
In girls, BMI showed a positive relationship with total WBC and neutrophil counts (table 269 
5), neutrophil percentages (supplementary table 5), and memory cell counts (CD3+CD45RO+ 270 
and CD4+CD45RO+) (table 6), and a negative one with percentages of CD8+CD45RA+ cells 271 
(supplementary table 6). 272 
 273 
DISCUSSION 274 
The current study describes the immune cell profile of a representative sample of healthy 275 
European adolescents. Our results show that sex, age, pubertal maturation and BMI are factors 276 
that influence normal circulating counts and percentages of immune cells in adolescents. 277 
 There were clear sex-related differences in the percentages and absolute counts of 278 
immune cells in our population. In general, girls had higher total WBC, neutrophil and memory 279 
T cells values (in particular, CD3+CD45RO+ and CD4+CD45RO+), while boys had higher 280 
percentages of lymphocytes and eosinophils, and higher counts of naïve T cells (all three subsets, 281 
CD3+CD45RA+, CD4+CD45RA and CD8+CD45RA+). Similar trends for differences in WBC 282 
between sexes were observed in a previous study in Spanish adolescents, although the authors 283 
did not find statistical significance [27]. With regards to lymphocyte subsets, our observations 284 
are also in agreement with previous studies [1, 28, 34]. On the contrary, other authors have found 285 
no effect of sex on WBC counts [38] or lymphocyte subsets [32] in adolescents. Sex dimorphism 286 
in WBC counts and percentages can be explained by differences in sex hormones, as suggested 287 
by Rudy and colleagues [28]. Sex hormones have been shown to modulate immune function at 288 
various levels, and a greater immune responsiveness has been observed in girls in general [12, 289 
35]. 290 
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A trend was observed towards higher WBC counts with age, in agreement with the 291 
findings reported by Bartlett and colleagues [1]. In particular, neutrophil counts were elevated in 292 
older boys and girls in our study; this led to increasing percentages of this cell type and 293 
decreasing percentages of lymphocytes in boys, while no significant changes in cell percentages 294 
with age were observed in girls. In contrast, age was associated with decreasing values for B 295 
cells (CD19+) leading to a higher CD3+/CD19+ ratio, and with a significant shift towards lower 296 
naïve/memory cells ratios. Lower B cell numbers with age were also observed by Bartlett [1]. 297 
Likewise, the changes in naïve and memory T cells are in agreement with previous studies [16, 298 
28], and coherent with an age-related maturation process of the immune system [32]. Age-sex 299 
interactions were observed: boys presented higher counts of naïve cells than girls, but the 300 
difference was ameliorated by age; in contrast, the counts of memory cells were higher in girls, 301 
and the gap increased with age. As a consequence, the changes in percentages of naïve and 302 
memory T cells, which were similar in both boys and girls, were the result of decreased naïve 303 
cell counts in boys, and of increased memory cell counts in girls. This difference between boys 304 
and girls could suggest a more mature or experienced immune system in the girls. As our 305 
adolescents were age-matched, the cause must be related to other parameters of growth rather 306 
than age, like pubertal maturation. 307 
 For that reason, pubertal maturation was considered for the analysis of immune cell 308 
profiles in our study. Similarly to age, the effect of pubertal maturation on WBC counts and 309 
percentages showed a distinct sex-related pattern. In boys, pubertal maturation was associated 310 
with lower WBC counts, lymphocyte counts and percentages; the decrease in lymphocyte counts 311 
was reflected in most subsets (CD3+, CD4+, CD8+, CD19+, CD3+CD45RA+, CD3+CD45RO+, 312 
CD8+CD45RA+ and surprisingly, also CD4+CD45RO+ and CD8+CD45RO+ cells). This could be 313 
explained by the physiological increase in androgen levels, mainly testosterone, since studies in 314 
men have reported negative associations between testosterone levels and WBC counts [3, 30]. In 315 
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girls, pubertal maturation was associated with increases in basophil counts and percentages and 316 
higher memory T cell counts. The lack of other significant relationships between pubertal 317 
maturation and immune cell counts could be related to the fact that the degree of pubertal 318 
maturation of the female sample in this study was high, with 82% of them being in the IV and V 319 
Tanner stages (in boys this proportion was lower, 73.7%). 320 
 Finally, BMI z-scores were also significantly associated with values of circulating 321 
immune cells in the studied population, and again the relationship was sex-specific. Higher BMI 322 
was in general associated with higher counts of total WBC and memory T cells (all three subsets 323 
in boys and CD3+CD45RO+ and CD4+CD45RO+ in girls). In boys, both neutrophils and 324 
lymphocytes were elevated, but the increase in lymphocytes was proportionally greater. In this 325 
line, in addition to memory cells, higher BMI z-scores in boys were also associated to elevated 326 
cell counts in most subsets (CD3+, CD4+, CD8+, NK, CD19+, and CD8+CD45RA+) and with a 327 
lower CD4+/CD8+ ratio. In girls, BMI was mainly linked to counts of neutrophils and memory 328 
cells. Alterations in immune parameters have been associated with both insufficient and 329 
excessive body weight [reviewed in 19 and 26]. In adults, positive associations were reported 330 
between BMI and circulating WBC, neutrophils, lymphocytes and monocytes [15]. Later, other 331 
authors have found similar age-independent, positive associations between WBC counts and 332 
BMI in children and adolescents [14, 36], in line with our observations. Furthermore, obesity in 333 
children and adolescents has been linked to elevated counts of neutrophils, monocytes, total T 334 
cells and helper T cells [37]. Our results, like those by Hsieh [14] and Wu [36], show that this 335 
increase is not merely the result of obesity, but it takes place in a linear manner with increasing 336 
BMI. It is worth highlighting this correlation, as WBC count has been related to features of the 337 
metabolic syndrome in both adult [10, 22] and paediatric populations [5, 14, 36], and a follow-up 338 
study in Japanese adults concluded that higher WBC counts were associated with higher risk of 339 
developing metabolic syndrome in the future [24]. The explanation for the relationship between 340 
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BMI and memory T cells or its potential implications is less straightforward. On the one hand, it 341 
could suggest that increasing BMI provides a more favorable environment for immune system 342 
development, similarly to age and pubertal maturation. On the other hand, we could instead be 343 
facing similar outcomes with different origins, and BMI-related changes could indicate abnormal 344 
or excessive activation of the immune system. This hypothesis would be supported by the 345 
relationships between circulating WBC and the metabolic syndrome mentioned above. However, 346 
the underlying processes linking nutritional status, BMI and immune function in children and 347 
adolescents clearly requires further research. 348 
In clinical practice to date, sex and age have been routinely taken into account for the 349 
establishment of normative ranges, since they constitute easy-to-obtain information. Other 350 
physiological features like pubertal maturation or BMI, however, are not frequently available or 351 
assessed when analysing blood variables. In light of ours and other authors’ results, we 352 
recommend considering these characteristics when setting reference values for or performing 353 
blood measurements in paediatric populations. 354 
Finally, two considerations should be made in relation to the present study. On the one 355 
hand, the number of subjects suitable for statistical analysis was not balanced in relation to the 356 
actual population size of each city. On the other, the sample studied included adolescents from 357 
different ethnic origins, and as it was mentioned above, ethnicity can be an influential factor for 358 
differences in WBC counts [1, 17, 38]. Despite these caveats, our work contributes to the 359 
development of a database of haematological reference values in healthy European adolescents. 360 
This is particularly strengthened by the use of standardized protocols and methods across all 361 
centres participating in the study. 362 
In conclusion, the present work provides data on normal values for white blood cell 363 
counts and percentages from healthy European adolescents, and highlights the importance of 364 
taking into account the influence of sex, age, the degree of pubertal maturation and BMI when 365 
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comparing or using white blood cell counts for clinical and research purposes in paediatric 366 
populations. 367 
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Table 1. White blood cell (WBC) counts (cell/μl) in European adolescents, according to age categories and stratified for sex. 594 
   Boys    Girls   
Age range (years) 12.5-13.9 14-14.9 15-15.9 16-17.5  12.5-13.9 14-14.9 15-15.9 16-17.5  
N  48 55 46 49 R 56 48 63 40 R 
WBC 10th 4,106  4,382 3,787§§ 4,630  0.107 4,493  4,368 4,934§§ 5,230 0.154* 
 25th 4,854 5,011 5,214§§ 5,055  5,151  5,202 5,670§§ 5,682  
 50th 5,721 5,706 6,100§§ 6,105  6,010  6,404 6,741§§ 6,520   
 75th 6,572 6,579 6,804§§ 6,810  6,929  7,823  8,011§§ 7,702   
 90th 7,605 8,000 7,568§§ 7,490  8,457  9,573 8,753§§ 8,350   
Neutrophils 10th 1,786§ 1,906§§  1,787§ 2,197§§  0.184* 2,310§ 1,870§§  2,138§  2,700§§  0.162* 
 25th 2,117§ 2,328§§ 2,371§ 2,576§§  2,834§ 2,587§§  2,860§  3,153§§  
 50th 2,940§ 2,681§§ 3,310§ 3,190§§  3,227§  3,555§§ 3,990§  3,835§§  
 75th 3,448§ 3,641§§ 3,984§ 3,635§§  3,898§ 4,873§§  4,900§  4,370§§   
 90th 4,771§ 4,458§§ 4,737§ 4,700§§  5,158§ 6,357§§ 5,591§  4,930§§   
Lymphocytes 10th 1,688 1,539   1,450 1,460 –0.130 1,483  1,418 1,570 1,700 0.054 
 25th 1,895 1,757 1,700 1,918  1,800  1,691 1,870 1,846  
 50th 2,200 2,241 2,040 2,120  2,100 2,141 2,140 1,960  
 75th 2,411 2,561 2,334 2,283  2,408 2,535 2,500 2,488  
 90th 3,106 2,887 2,768 2,960  2,663 3,088 3,003 2,940  
Monocytes 10th 295 300 330 300  0.074 324 280 350 280 0.092 
 25th 360 370 376 399  395 340 400 376  
 50th 420 461 445 460  440 430 500 510  
 75th 522 600 543 510  514 551 570 578  
 90th 700 769 648 620  700 743 714 610  
Eosinophils 10th  80 80 40 60 –0.056 57 49 64 60 -0.074 
 25th 100 100 100 100  100 80 100 70  
 50th 119 160 140 135  137 130 125 110  
 75th 200 224 232 191  230 200 200 186  
 90th 300 400 455 310  424 255 334 280  
Basophils 10th 0 0 0 0 0.029 0 1 0 0 0.090 
 25th 0 10 8 20  0 10 10 20  
 50th 20 20 20 30  20 30 30 20  
 75th 40 45 30 31  33 40 50 40  
 90th 79 92 64 60  58 76 100 50  
Data are presented as percentiles 10th, 25th, 50th (median), 75th, and 90th. §Significant differences between boys and girls for a given age category, as assessed by the 595 
Mann-Whitney U test, §P<0.05, §§P<0.01. R is the partial correlation coefficient between cell counts and age, controlling for centre; bold rows indicate significant 596 
correlations,*P<0.05, **P<0.01.  597 
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Table 2. Estimated cell counts (cell/μl) of selected lymphocyte subsets in adolescents, according to age categories and stratified for sex. 598 
   Boys    Girls   
Age range (years) 12.5-13.9 14-14.9 15-15.9 16-17.5  12.5-13.9 14-14.9 15-15.9 16-17.5  
N  36 49 41 45 R 39 42 50 26 R 
CD3+ 10th 1,147 1,005 952 943 -0.149 1,041 922 1,117 1,151 0.081 
 25th 1,239 1,208 1,139 1,145  1,278 1,138 1,291 1,275  
 50th 1,477 1,524 1,355 1,464  1,384 1,498 1,536 1,374  
 75th 1,758 1,737 1,695 1,598  1,573 1,772 1,951 1,819  
 90th 2,330 1,974 2,002 2,127  1,889 2,124 2,180 1,930  
CD4+ 10th 580 535 491 487 -0.139 573 459 616 567 0.109 
 25th 652 660 628 581  651 612 706 687  
 50th 806 824 771 791  779 789 842 785  
 75th 1,055 962 902 972  888 950 1,054 1,095  
 90th 1,154 1,150 1,044 1,070  1,057 1,181 1,292 1,212  
CD8+ 10th 372 349 343 309 -0.154* 393 333 392 383 0.009 
 25th 490 443 441 358  442 425 463 472  
 50th 541 601 531 539  581 558 584 515  
 75th 770 724 704 683  672 735 725 633  
 90th 1,016 915 850 888  757 970 983 725  
CD3–CD16+56+ 10th 164 119 145 165 -0.030 148 172 168 138 0.022 
 25th 248 201 222 217  191 242 238 180  
 50th 333 298 350 376  275 312 312 322  
 75th 410 417 447 447  434 418 388 400  
 90th 754 647 562 542  579 531 507 784  
CD3–CD19+ 10th 160 157 153 131 -0.263** 181 140 150 99 -0.266** 
 25th 221 198 195 174  231 196 174 127  
 50th 286 283 251 219  267 244 238 241  
 75th 333 377 311 279  385 304 299 285  
 90th 514 514 439 375  501 409 354 321  
CD3+CD45RA+ 10th 637 643§ 485 461 -0.199* 570 510§ 609 535 -0.016 
 25th 770 735§ 711 612  718 660§ 678 673  
 50th 958 1,000§ 809 860  870 815§ 887 824  
 75th 1,113 1,138§ 1,016 1,001  1,024 1,015§ 1,149 911  
 90th 1,448 1,218§ 1,213 1,195  1,236 1,386§ 1,408 1,193  
CD3+CD45RO+ 10th 346 332§ 317 385§ -0.016 347 322§ 437 517§ 0.237** 
 25th 451 437§ 392 463§  440 475§ 530 572§  
 50th 526 482§ 564 575§  520 630§ 625 660§  
 75th 735 674§ 705 672§  619 778§ 749 791§  
 29 
 90th 867 807§ 847 832§  818 897§ 928 942§  
CD4+CD45RA+ 10th 306 311§ 248 201 -0.196* 306 232§ 287 197 -0.042 
 25th 382 381§ 322 304  364 288§ 343 347  
 50th 497 524§ 416 418  479 422§ 448 451  
 75th 626 629§ 482 596  570 590§ 643 512  
 90th 752 709§ 640 708  716 694§ 744 590  
CD4+CD45RO+ 10th 227 194 194 256§ 0.006 205 187 279 261§ 0.344** 
 25th 245 251 234 292§  252 269 313 338§  
 50th 313 304 338 337§  291 358 371 389§  
 75th 414 430 442 406§  343 428 483 566§  
 90th 487 556 508 466§  401 522 540 644§  
CD8+CD45RA+ 10th 268 249 221 206 -0.186* 200 203 255 230 0.021 
 25th 311 298 285 231  282 271 299 301  
 50th 384 414 362 367  380 342 391 334  
 75th 489 523 505 446  471 450 543 441  
 90th 645 663 619 603  574 558 678 497  
CD8+CD45RO+ 10th 90 65 79 78 -0.036 84 85 92 94 0.032 
 25th 107 98 102 110  118 130 128 139  
 50th 164 159 152 155  146 182 180 173  
 75th 224 225 199 224  217 290 231 213  
 90th 264 290 249 328  313 354 300 240  
CD4+/CD8+ 10th 1.04 0.85 0.98 0.87 0.051 1.03 0.89 1.00 1.14 0.104 
 25th 1.16 1.21 1.16 1.13  1.22 1.11 1.19 1.24  
 50th 1.29 1.49 1.36 1.62  1.44 1.46 1.55 1.56  
 75th 1.58 1.86 1.78 1.97  1.64 1.64 1.78 1.87  
 90th 2.18 2.23 2.22 2.36  1.98 2.02 2.11 2.86  
CD3+/CD19+ 10th 3.08 3.10 3.44§ 3.90 0.189* 3.04 3.62 3.99§ 4.74 0.311** 
 25th 4.32 3.75 4.02§ 5.24  3.87 4.06 5.27§ 6.10  
 50th 5.95 5.25 5.82§ 6.11  4.75 5.69 6.61§ 6.89  
 75th 7.10 7.14 6.90§ 7.74  6.68 7.14 8.31§ 9.93  
 90th 8.71 9.24 8.58§ 10.76  7.87 11.00 12.04§ 13.79  
Data are presented as percentiles 10th, 25th, 50th (median), 75th, and 90th. Lymphocyte populations are designated by their cell markers. § Significant differences 599 
between boys and girls for a given age category, as assessed by the Mann-Whitney U test; §P<0.05, §§P<0.01. R is the partial correlation coefficient between 600 
cell counts and age, controlling for centre; bold rows indicate significant correlations,*P<0.05, **P<0.01. 601 
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Table 3. White blood cell (WBC) counts (cell/μl) in European adolescents, according to Tanner stages and stratified for sex. 603 
  Boys Girls 
Tanner stage I+II III IV V  I+II III IV V  
N  12 34 77 55 P 7 26 97 60 P 
WBC 10th 4,073 4,803 4,160 4,357 0.037 3,920 4,353 4,696 4,995 0.404 
 25th 4,751 5,469 4,940 4,946  4,423 5,030 5,481 5,357  
 50th 6,050 5,965 5,706 5,938  5,091 6,065 6,541 6,500  
 75th 7,271 6,769 6,581 6,811  6,878 8,179 7,612 8,003  
 90th 9,129 8,273 7,454 7,300  - 9,581 8,693 8,400  
Neutrophils 10th 1,243 2,129 1,766 2,021 0.068 1,290 1,908 2,153 2,444 0.089 
 25th 2,158 2,833 2,169 2,447  1,543 2,361 2,864 2,975  
 50th 3,095 3,206 2,891 3,210  2,259 3,515 3,599 3,662  
 75th 4,057 3,636 3,504 4,000  3,601 5,056 4,486 4,699  
 90th 4,794 5,097 4,197 4,710  - 7,111 5,335 5,476  
Lymphocytes 10th 1,803 1,650 1,537 1,298 0.002 1,550 1,385 1,566 1,500 0.981 
 25th 1,898 1,880 1,903 1,575  1,917 1,658 1,850 1,828  
 50th 2,247 2,138 2,155 1,935  2,122 2,097 2,120 2,140  
 75th 2,984 2,567 2,397 2,310  2,339 2,468 2,510 2,500  
 90th 3,845 3,275 2,870 2,728  - 2,790 2,991 2,893  
Monocytes 10th 350 299 290 316 0.825 340 279 331 291 0.873 
 25th 367 360 350 382  346 362 400 370  
 50th 420 408 420 469  392 452 494 439  
 75th 540 540 521 510  702 570 570 526  
 90th 661 720 618 632  - 735 671 627  
Eosinophils 10th 85 54 50 69 0.922 51 61 60 74 0.206 
 25th 111 100 100 100  98 94 80 100  
 50th 164 150 130 130  130 158 110 140  
 75th 219 220 223 203  165 263 200 200  
 90th 428 426 311 358  - 513 280 354  
Basophils 10th 5 0 4 0 0.061 10 1 0 0 0.011 
 25th 22 16 10 9  15 10 10 20  
 50th 38 20 20 20  30 29 20 30  
 75th 41 40 30 40  40 32 40 60  
 90th 60 74 46 60  - 72 50 100  
Data are presented as percentiles 10th, 25th, 50th (median), 75th, and 90th. Bold rows indicate significant differences between Tanner stages, as 604 
assessed by analysis of covariance (ANCOVA), controlling for centre and age, P<0.05.  605 
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Table 4. Estimated cell counts (cell/μl) of selected lymphocyte subsets in European adolescents, according to Tanner stages and stratified for sex. 606 
  Boys Girls 
Tanner stage I+II III IV V  I+II III IV V  
N  9 26 67 52 P 7 19 65 55 P 
CD3+ 10th 1,157 1,039 1,066 876 0.002 1,135 819 1,112 1,089 0.362 
 25th 1,259 1,401 1,237 1,007  1,295 990 1,236 1,202  
 50th 1,694 1,517 1,467 1,316  1,366 1,364 1,470 1,549  
 75th 2,095 1,903 1,672 1,526  1,466 1,575 1,835 1,858  
 90th - 2,254 1,991 1,909  - 1,938 2,205 2,051  
CD4+ 10th 584 542 551 479 0.010 632 477 585 572 0.308 
 25th 644 735 681 575  727 593 684 652  
 50th 780 894 835 737  815 689 827 834  
 75th 1,084 960 994 882  881 862 1,080 1,015  
 90th 1,457 1,168 1,143 1,014  - 1,069 1,252 1,223  
CD8+ 10th 492 383 347 279 0.012 330 291 382 392 0.325 
 25th 510 454 430 358  412 388 447 455  
 50th 671 602 554 464  528 478 559 590  
 75th 822 843 692 653  606 632 676 733  
 90th 1,026 1,038 780 846  - 815 883 938  
CD3–CD16+56+ 10th 247 161 136 149 0.067 119 127 168 170 0.536 
 25th 276 249 210 210  185 183 241 221  
 50th 319 357 342 323  326 304 339 286  
 75th 506 430 446 455  496 360 440 375  
 90th - 687 540 590  - 540 554 571  
CD3–CD19+ 10th 162 182 159 116 0.049 144 152 137 128 0.078 
 25th 210 209 200 172  169 185 217 171  
 50th 282 276 256 225  342 240 273 232  
 75th 337 325 359 287  418 293 321 289  
 90th - 586 460 398  - 466 417 355  
CD3+CD45RA+ 10th 737 649 591 476 0.024 745 515 528 533 0.698 
 25th 814 754 732 582  832 631 666 674  
 50th 1,005 980 939 777  901 727 846 901  
 75th 1,405 1,189 1,094 975  1,016 1,039 1,056 1,076  
 90th - 1,294 1,193 1,129  - 1,329 1,427 1,297  
CD3+CD45RO+ 10th 354 394 356 297 <0.001 304 284 422 465 0.021 
 25th 477 486 459 373  357 354 474 528  
 50th 549 592 559 467  454 479 634 636  
 75th 722 775 682 585  536 684 784 753  
 32 
 90th - 907 777 776  - 813 918 942  
CD4+CD45RA+ 10th 318 331 227 238 0.102 388 263 245 235 0.824 
 25th 408 355 370 296  472 332 363 332  
 50th 487 449 491 384  538 390 475 426  
 75th 639 667 629 506  565 608 598 580  
 90th 783 769 701 646  - 720 740 729  
CD4+CD45RO+ 10th 213 198 227 191 0.005 186 182 241 270 0.025 
 25th 235 293 280 233  239 203 289 314  
 50th 303 400 327 303  281 283 363 387  
 75th 352 457 419 361  306 312 445 493  
 90th 851 487 505 485  - 398 558 619  
CD8+CD45RA+ 10th 336 282 222 219 0.032 193 201 228 257 0.473 
 25th 367 316 297 245  247 256 301 288  
 50th 458 413 383 325  407 325 363 412  
 75th 622 540 451 446  509 440 469 499  
 90th - 684 593 624  - 560 631 649  
CD8+CD45RO+ 10th 107 88 79 49 0.008 61 60 105 94 0.069 
 25th 120 117 109 89  82 103 128 138  
 50th 159 160 164 130  109 150 171 186  
 75th 211 242 199 197  166 236 229 268  
 90th - 366 261 246  - 320 303 332  
CD4+/CD8+ 10th 1.09 0.98 0.99 0.92 0.478 1.04 0.90 1.16 0.94 0.349 
 25th 1.13 1.12 1.22 1.14  1.26 1.21 1.27 1.14  
 50th 1.20 1.28 1.55 1.43  1.78 1.52 1.50 1.48  
 75th 1.39 1.72 1.93 1.91  2.14 1.79 1.76 1.77  
 90th 1.48 2.07 2.15 2.47  - 2.03 2.11 1.99  
CD3+/CD19+ 10th 3.09 3.40 3.28 3.54 0.417 2.99 3.71 3.64 3.86 0.257 
 25th 5.34 4.81 4.37 4.13  3.22 4.04 4.73 4.97  
 50th 6.38 5.38 5.79 5.79  4.47 5.12 5.56 6.77  
 75th 7.28 7.28 6.97 7.68  7.09 7.35 7.32 9.68  
 90th - 8.08 8.11 10.96  - 10.56 10.54 11.78  
Data are presented as percentiles 10th, 25th, 50th (median), 75th, and 90th. Lymphocyte populations are designated by their cell markers. Bold rows indicate significant 607 
differences between Tanner stages, as assessed by analysis of covariance (ANCOVA), controlling for centre and age, P<0.05. 608 
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Table 5. White blood cell (WBC) counts (cell/μl) in European adolescents, according to BMI z-scores and stratified for sex. 610 
  Boys Girls 
BMI z-scores Q1 Q2 Q3 Q4   Q1 Q2 Q3 Q4   
N  43 42 42 43 P R 41 41 38 39 P R 
WBC 10th 4,629 4,180 4,160 5,175 0.001 0.195** 4,392 4,484 5,208 5,221 0.005 0.208** 
 25th 5,223 4,700 4,909 5,775   5,054 5,101 5,716 5,772   
 50th 6,079 5,463 5,711 6,403   6,260 6,300 6,804 6,574   
 75th 6,512 6,504 6,781 7,200   7,161 7,751 7,938 8,321   
 90th 7,709 7,150 7,487 8,825   8,221 8,480 9,068 9,836   
Neutrophils 10th 2,032 1,769 1,893 2,211 0.020 0.115 1,799 2,225 2,529 2,644 0.003 0.224** 
 25th 2,381 2,275 2,111 2,800   2,693 2,636 3,000 3,170   
 50th 3,084 2,799 2,910 3,269   3,190 3,512 3,806 4,146   
 75th 3,791 3,539 3,537 4,009   4,200 4,384 4,902 5,070   
 90th 4,658 4,387 4,308 5,042   4,666 5,646 6,021 6,287   
Lymphocytes 10th 1,373 1,456 1,551 1,879 <0.001 0.331** 1,590 1,497 1,488 1,367 0.806 0.029 
 25th 1,703 1,671 1,729 2,170   1,829 1,694 1,856 1,870   
 50th 2,060 1,992 2,089 2,380   2,093 2,035 2,195 2,122   
 75th 2,378 2,190 2,331 2,817   2,482 2,456 2,439 2,552   
 90th 2,676 2,553 2,862 3,157   2,834 2,940 2,802 3,092   
Monocytes 10th 300 300 319 300 0.261 0.115 294 284 349 300 0.224 0.071 
 25th 363 388 370 380   390 363 413 370   
 50th 420 420 460 500   476 432 500 463   
 75th 511 500 583 580   559 553 555 600   
 90th 672 613 660 709   665 654 707 733   
Eosinophils 10th 80 90 50 50 0.066 –0.095 70 60 50 50 0.742 0.034 
 25th 100 100 100 100   90 95 81 100   
 50th 139 130 190 120   120 105 143 100   
 75th 209 190 277 180   200 200 220 200   
 90th 307 320 516 246   316 272 300 398   
Basophils 10th 0 0 0 0 0.506 –0.126 0 0 0 0 0.527 –0.045 
 25th 10 10 10 10   11 10 10 0   
 50th 30 20 20 20   30 21 21 20   
 75th 50 30 40 30   47 35 50 40   
 90th 70 45 60 60   100 50 80 100   
Data are presented as percentiles 10th, 25th, 50th (median), 75th, and 90th. Bold rows indicate significant differences between quartiles of standardized body mass index values 611 
(BMI z-scores), as assessed by analysis of covariance (ANCOVA), controlling for centre, P<0.05. R is the partial correlation coefficient between cell counts and BMI z-scores, 612 
controlling for centre, *P<0.05, **P<0.01. 613 
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Table 6. Estimated cell counts (cell/μl) of lymphocyte subsets in European adolescents, according to BMI z-scores and stratified for sex. 614 
  Boys Girls 
BMI z-scores Q1 Q2 Q3 Q4   Q1 Q2 Q3 Q4   
N  43 42 42 43 P R 41 41 38 39 P R 
CD3+ 10th 850 994 958 1,244 0.014 0.238** 1,084 1,017 946 1,126 0.301 0.122 
 25th 1,083 1,088 1,162 1,411   1,158 1,183 1,269 1,314   
 50th 1,457 1,238 1,476 1,696   1,382 1,364 1,523 1,517   
 75th 1,657 1,590 1,622 1,978   1,578 1,756 1,741 1,881   
 90th 2,038 1,740 1,979 2,269   1,986 2,165 1,930 2,301   
CD4+ 10th 443 529 551 591 0.085 0.174* 579 522 572 621 0.265 0.164* 
 25th 632 600 617 749   620 649 671 723   
 50th 808 748 788 942   711 783 871 845   
 75th 957 858 895 1,086   903 960 1,020 1,075   
 90th 1,139 1,053 982 1,178   1,248 1,224 1,145 1,237   
CD8+ 10th 280 300 346 425 0.009 0.266** 385 359 381 373 0.634 0.067 
 25th 386 380 413 537   413 455 434 463   
 50th 507 492 554 659   526 552 557 578   
 75th 649 643 684 864   700 681 711 713   
 90th 852 758 809 1,013   863 787 782 1,046   
CD3–CD16+56+ 10th 149 149 137 192 0.042 0.192* 119 150 154 181 0.766 0.064 
 25th 222 204 198 303   191 216 199 240   
 50th 307 323 282 389   320 275 307 320   
 75th 374 422 437 558   464 361 400 403   
 90th 463 491 579 704   565 496 531 570   
CD3–CD19+ 10th 131 153 152 186 0.013 0.221** 145 105 153 132 0.700 –0.001 
 25th 185 169 202 224   185 167 202 188   
 50th 239 219 286 287   257 239 266 241   
 75th 291 281 352 433   316 288 327 310   
 90th 417 336 482 502   430 431 397 422   
CD3+CD45RA+ 10th 469 505 513 642 0.413 0.133 577 513 522 556 0.962 0.036 
 25th 699 649 700 789   664 633 717 695   
 50th 928 808 905 1,015   805 880 878 857   
 75th 1,113 976 1,040 1,215   1,003 1,097 1,031 1,073   
 90th 1,192 1,112 1,193 1,365   1,282 1,455 1,267 1,429   
CD3+CD45RO+ 10th 292 356 339 479 0.003 0.266** 367 426 393 456 0.036 0.171* 
 25th 375 401 441 572   454 486 456 556   
 50th 475 499 514 690   556 569 576 656   
 75th 636 589 649 780   696 731 745 775   
 35 
 90th 819 654 874 914   880 903 861 940   
CD4+CD45RA+ 10th 216 263 259 234 0.932 0.045 223 247 244 266 0.917 0.034 
 25th 357 314 328 368   336 330 362 348   
 50th 483 391 453 475   428 449 488 424   
 75th 613 501 543 637   567 596 577 598   
 90th 718 705 667 719   655 828 709 690   
CD4+CD45RO+ 10th 191 204 196 278 0.002 0.261** 225 225 219 261 0.012 0.254** 
 25th 227 256 254 308   274 286 289 306   
 50th 291 302 328 408   313 362 341 398   
 75th 410 373 399 487   387 406 438 493   
 90th 487 436 466 556   533 485 612 620   
CD8+CD45RA+ 10th 220 227 222 291 0.131 0.191* 248 199 230 199 0.854 0.033 
 25th 246 252 287 348   279 292 298 297   
 50th 382 343 370 431   341 373 380 373   
 75th 471 446 450 609   474 462 486 472   
 90th 549 489 638 713   570 568 635 697   
CD8+CD45RO+ 10th 51 74 89 110 0.019 0.248** 84 113 88 92 0.060 0.095 
 25th 85 97 107 150   127 135 110 155   
 50th 144 133 150 206   158 172 155 209   
 75th 190 196 197 236   229 233 226 266   
 90th 242 244 312 300   290 334 290 336   
CD4+/CD8+ 10th 0.91 1.07 1.08 0.91 0.286 –0.161* 0.89 1.03 1.15 0.99 0.713 0.100 
 25th 1.16 1.20 1.21 1.05   1.09 1.23 1.24 1.20   
 50th 1.54 1.41 1.36 1.30   1.43 1.43 1.55 1.51   
 75th 2.03 1.91 1.70 1.71   1.84 1.72 1.75 1.83   
 90th 2.48 2.36 2.04 2.19   2.05 2.10 1.95 2.15   
CD3+/CD19+ 10th 3.58 3.74 3.12 3.44 0.250 –0.057 3.74 3.71 3.71 3.70 0.336 0.094 
 25th 4.02 5.34 3.74 4.56   4.03 4.60 4.75 5.44   
 50th 5.89 6.07 4.73 5.46   5.33 6.31 5.57 6.77   
 75th 7.85 7.12 6.74 7.11   7.87 8.54 6.68 7.63   
 90th 9.90 7.67 10.24 8.61   10.90 13.48 9.29 11.50   
Data are presented as percentiles 10th, 25th, 50th (median), 75th, and 90th. Lymphocyte populations are designated by their cell membrane markers. Bold rows indicate 615 
significant differences between quartiles of standardized body mass index (BMI z-scores), as assessed by analysis of covariance (ANCOVA), controlling for centre, 616 
P<0.05. R is the partial correlation coefficient between cell counts and BMI z-scores, controlling for centre; *P<0.05, **P<0.01. 617 
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